Association of proteomic markers with nutritional risk and response to nutritional support: a secondary pilot study of the EFFORT trial using an untargeted proteomics approach
Evaluation of the therapeutic potential of resveratrol-loaded nanostructured lipid carriers on autosomal recessive spastic ataxia of Charlevoix-Saguenay patient-derived fibroblasts